Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Cash Flows from Operating Activities:
Net income	$ 3,521	$ 3,072	$ 3,889
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, depletion and amortization	1,798	1,633	1,577
Loss on impairments	161	357	0
Share-based compensation	125	123	101
Gains on disposals from discontinued operations, businesses and long-lived assets, net	(431)	(66)	(1,422)
Deferred tax expense (benefit)	180	(64)	(63)
Loss from equity method investments	108	17	0
Pension and other postretirement benefits net periodic benefit cost	34	31	30
Non-cash operating lease costs	262	293	273
Other items, net	14	68	45
Changes in operating assets and liabilities, net of effects of acquisitions and divestitures:
Accounts receivable, net	(122)	(164)	(226)
Inventories	(224)	(60)	(655)
Accounts payable	48	144	403
Operating lease liabilities	(287)	(276)	(269)
Other assets	(69)	25	(45)
Other liabilities	(86)	(72)	205
Pension and other postretirement benefits contributions	(43)	(44)	(43)
Net cash provided by operating activities	4,989	5,017	3,800
Cash Flows from Investing Activities:
Purchases of property, plant and equipment, and intangibles	(2,578)	(1,817)	(1,523)
Acquisitions, net of cash acquired	(4,900)	(640)	(3,253)
Deferred divestiture consideration received	1,001	0	3,712
Proceeds from disposal of long-lived assets	272	104	115
Dividends received from equity method investments	44	44	36
Settlements of derivatives	(9)	(1)	(11)
Deferred divestiture consideration received	83	6	52
Other investing activities, net	(204)	(87)	(45)
Net cash used in investing activities	(6,291)	(2,391)	(917)
Cash Flows from Financing Activities:
Proceeds from debt issuances	4,001	3,163	38
Payments on debt	(1,859)	(1,462)	(364)
Settlements of derivatives	(36)	7	(11)
Payments of finance lease obligations	(57)	(26)	(28)
Deferred and contingent acquisition consideration paid	(21)	(22)	(24)
Dividends paid	(1,706)	(940)	(917)
Distributions to noncontrolling and redeemable noncontrolling interests	(53)	(35)	(23)
Transactions involving noncontrolling interests	19	(2)	(3)
Repurchases of common stock	(1,482)	(3,067)	(1,178)
Proceeds from exercise of stock options	8	4	11
Net cash used in financing activities	(1,186)	(2,380)	(2,499)
Effect of exchange rate changes on cash and cash equivalents, including restricted cash	(143)	208	(231)
(Decrease)/increase in cash and cash equivalents, including restricted cash	(2,631)	454	153
Cash and cash equivalents and restricted cash at the beginning of year	6,390	5,936	5,783
Cash and cash equivalents and restricted cash at the end of year	3,759	6,390	5,936
Supplemental cash flow information:
Cash paid for interest (including finance leases)	599	418	329
Cash paid for income taxes	960	959	1,043
Reconciliation of cash and cash equivalents and restricted cash
Cash and cash equivalents presented in the Consolidated Balance Sheets	3,720	6,341	5,936
Restricted cash presented in the Consolidated Balance Sheets	39	0	0
Cash and cash equivalents included in Assets held for sale	0	49	0
Total cash and cash equivalents and restricted cash presented in the Consolidated Statements of Cash Flows	$ 3,759	$ 6,390	$ 5,936